Conduct Study Sample Clauses

Conduct Study. (1) Contractor will conduct an ongoing comprehensive rates study to evaluate the existing Long-Term Supports and Services landscape within Washington State and throughout the nation in the private sector to inform a report outlining options for rate maximums for the WA Cares services array.
AutoNDA by SimpleDocs
Conduct Study. The TTI/ITE team shall conduct a study based upon the approved work plan, collect data and conduct an evaluation. During the data collection and analysis, the TTI/ITE team shall implement quality control procedures to ensure that data integrity is maintained. All relevant evaluation data collected or gathered under this effort shall be delivered to the TOCOR, by the TTI/ITE team, at the end of this task in an electronic NDS data format agreed to by the TOCOR with appropriate documentation of the data. In addition to the information provided in the monthly progress reports, the contractor shall, on a bi-weekly regular basis, inform the TOCOR of data collection scheduling to allow the government to observe data collection efforts, if so desired. At the conclusion of the evaluation, the TTI/ITE team shall prepare a draft technical memorandum detailing the findings of the evaluation. Deliverable: • Evaluation technical memorandum
Conduct Study. The Contractor shall conduct a study based upon the approved work plan, collect data and conduct an evaluation. During the data collection and analysis, the Contractor shall implement quality control procedures to ensure that data integrity is maintained. All relevant evaluation data collected or gathered under this effort shall be delivered to the TOCOR, by the Contractor, at the end of this task in an electronic NDS data format agreed to by the TOCOR with appropriate documentation of the data. In addition to the information provided in the monthly progress reports, the contractor shall, on a bi-weekly regular basis, inform the TOCOR of data collection scheduling to allow the government to observe data collection efforts, if so desired. At the conclusion of the evaluation, the contractor shall prepare a draft technical memorandum detailing the findings of the evaluation. Deliverable: Evaluation technical memorandum
Conduct Study o Survey Deployment – OCI will develop an online survey using the survey question included in the QAPP. This is expected to include: ▪ Convert the QAPP survey questions to an electronic format using Survey Monkey (or similar free online survey tool) and deploy the survey to the participants. ▪ Follow-up with each participant each week following the dissemination of the survey, up to four times via email to increase participation ▪ The survey will be open for a predefined time (to be determined when the project schedule is developed). Survey responses received after the survey has closed will not be included in the study. ▪ We have budgeted 18 hours for this subtask.

Related to Conduct Study

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Trials The Ship shall run the following test and trials:

  • Clinical 2.1 Provides comprehensive evidence based nursing care to patients including assessment, intervention and evaluation.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Study An application for leave of absence for professional study must be supported by a written statement indicating what study or research is to be undertaken, or, if applicable, what subjects are to be studied and at what institutions.

  • Professional Development Activities Professional development activities are activities initiated by individual faculty members or groups of faculty members and may include attendance at conferences, workshops or seminars which facilitate the following:

  • Professional Study Permanent unit members may apply for professional study leave by outlining in writing the plan that is to be followed and the institution to be attended. In addition, a clear statement must be included in the request indicating the need for educational study and the potential value to the District upon completion of such study. (See Appendix A, 4.033)

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Re-Study If Re-Study of the Interconnection Facilities Study is required due to a higher queued project dropping out of the queue or a modification of a higher queued project pursuant to Section 4.4, Transmission Provider shall so notify Interconnection Customer in writing. Such Re-Study shall take no longer than sixty (60) Calendar Days from the date of notice. Any cost of Re-Study shall be borne by the Interconnection Customer being re-studied.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!